Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences Track

A simplified method for the diagnosis of striatal dopaminergic dysfunction using PET with a new fluorine DAT tracer, the 18F-LBT-999

Maria-Joao SANTIAGO-RIBEIRO, Johnny Vercouillie, Nicolas ARLICOT, Karl MONDON, Val?rie Gissot, Serge MAIA, Laurent BARANTIN, Jean-Philippe Cottier, Jean-Bernard DELOYE and Denis Guilloteau
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 413;
Maria-Joao SANTIAGO-RIBEIRO
7Université François Rabelais, Inserm U 930, CHRU, CIC-IT 1415 Tours France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johnny Vercouillie
1Tours France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas ARLICOT
7Université François Rabelais, Inserm U 930, CHRU, CIC-IT 1415 Tours France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl MONDON
7Université François Rabelais, Inserm U 930, CHRU, CIC-IT 1415 Tours France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Val?rie Gissot
5CIC 1415 Tours France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Serge MAIA
2CHRU Tours France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent BARANTIN
7Université François Rabelais, Inserm U 930, CHRU, CIC-IT 1415 Tours France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Philippe Cottier
4CHU Bretonneau Tours France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Bernard DELOYE
6Laboratoires Cyclopharma Clermont-Ferrand France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denis Guilloteau
3CHRU de Tours Tours France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

413

Objectives: Parkinson's (PD) or Lewy body dementia characterized by a degeneration of the presynaptic dopaminergic neurons can be in vivo explored with SPECT DAT ligands. Nevertheless, as this type of exams present some drawbacks many efforts have been made to develop PET DAT radioligands either labelled with C-11 or F-18. We report here the quantitative evaluation of the presynaptic dopaminergic neurons impairment in parkinsonian patients using a new F-18 DAT ligand, the 18F-LBT-999.

Methods: Six PD patients (age: 69±7 y, Hoehn and Yahr: stage I-II) and eight 8 controls (age: 69±9y) were studied with an Ingenuity Philips tomograph. A 90-min dynamic PET followed an iv injection of 18F-LBT (3.6 MBq/kg). The binding potential (BP) using SRTM method as also the ratios obtained for a 10-min image acquired between 30 and 40 min pi were calculated in the caudate nucleus (Cd) and in the putamen (Pu) using regions of interest (ROI) defined over each T1 3D MRI. The cerebellum activity was used as reference region.

Results: In PD patients and for both striatal structures, BP and ratios were significantly decreased compared to control group (p<0.001). For PD group, the mean±SD BP values were 3.97±1.32 and 2.72±1.51, and the ratios 3.76±0.82 and 3.12±0.80, for Cd and Pu, respectively. For control group, the values were for BP 6.30±1.17 and 6.75±1.17 and for ratios 5.01±0.68 and 5.40±0.73, for Cd and Pu, respectively.

Conclusion: Our results indicate that the use of striatal ratios using a 10 minutes PET acquisition is reliable to differentiate early PD patients to controls. Moreover, the findings using ratios are in accordance with those obtained using a dynamic acquisition with a SRTM analysis of a 90-min dynamic PET scan. Research Support: This study was supported by the French National Agency for Research (‘‘Investissements d’Avenir’’ ANR-11-LABX-0018-01), IRON and by Cyclopharma Laboratories. We thank the technical and nursing staffs of CERRP, the Service de Médecine Nucléaire, CIC-IT, CHRU Tours for their assistance.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A simplified method for the diagnosis of striatal dopaminergic dysfunction using PET with a new fluorine DAT tracer, the 18F-LBT-999
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
A simplified method for the diagnosis of striatal dopaminergic dysfunction using PET with a new fluorine DAT tracer, the 18F-LBT-999
Maria-Joao SANTIAGO-RIBEIRO, Johnny Vercouillie, Nicolas ARLICOT, Karl MONDON, Val?rie Gissot, Serge MAIA, Laurent BARANTIN, Jean-Philippe Cottier, Jean-Bernard DELOYE, Denis Guilloteau
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 413;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A simplified method for the diagnosis of striatal dopaminergic dysfunction using PET with a new fluorine DAT tracer, the 18F-LBT-999
Maria-Joao SANTIAGO-RIBEIRO, Johnny Vercouillie, Nicolas ARLICOT, Karl MONDON, Val?rie Gissot, Serge MAIA, Laurent BARANTIN, Jean-Philippe Cottier, Jean-Bernard DELOYE, Denis Guilloteau
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 413;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences Track

  • Impact of cognitive reserve in frontotemporal dementia illustrated by FDG-PET.
  • Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with 18F-FEOBV
  • Kinetic evaluation of [18F]MOZAT PET imaging in humans.
Show more Neurosciences Track

New Approaches to Image Parkinson Syndrome

  • Utility of F-18-THK-5351 Tau-PET for Differential Diagnosis in Patients with Hypokinetic-rigid Syndromes
  • Management impact of imaging brain vesicular monoamine transporter type-2 (VMAT2) in clinically uncertain parkinsonian syndrome (CUPS) with 18F-AV133 and PET
  • Comparing patterns of brain amyloid deposition in Parkinson’s disease to Alzheimer’s disease and cognitively normal controls using [18F] florbetapir PET imaging
Show more New Approaches to Image Parkinson Syndrome

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire